dc.creator | França, Maria Eduarda Rocha de | |
dc.creator | Rocha, Sura Wanessa Santos | |
dc.creator | Oliveira, Wilma Helena | |
dc.creator | Santos, Laise Aline | |
dc.creator | Oliveira, Anne Gabrielle Vasconcelos de | |
dc.creator | Barbosa, Karla Patrícia Sousa | |
dc.creator | Nunes, Ana Karolina Santana | |
dc.creator | Rodrigues, Gabriel Barros | |
dc.creator | Lós, Deniele Bezerra | |
dc.creator | Peixoto, Christina Alves | |
dc.date | 2019-11-22T14:31:31Z | |
dc.date | 2019-11-22T14:31:31Z | |
dc.date | 2018 | |
dc.date.accessioned | 2023-09-26T22:52:42Z | |
dc.date.available | 2023-09-26T22:52:42Z | |
dc.identifier | FRANÇA, Maria Eduarda Rocha de et al. Diethylcarbamazine attenuates the expression of pro-fibrogenic markers and hepatic stellate cells activation in carbon tetrachloride-induced liver fibrosis. Inflammopharmacology, v. 26, n. 2, p. 599–609, abr. 2018. | |
dc.identifier | 0925-4692 | |
dc.identifier | https://www.arca.fiocruz.br/handle/icict/37294 | |
dc.identifier | 10.1007/s10787-017-0329-0 | |
dc.identifier | 1568-5608 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/8884277 | |
dc.description | CAPES; UFPE; IAM / FIOCRUZ | |
dc.description | While diethylcarbamazine citrate (DEC) displays important anti-inflammatory effects in experimental models of liver injury, the mechanisms of its action remain poorly understood. The aim of the present study was to investigate the fibrolytic potential of DEC. | |
dc.description | 2050-01-01 | |
dc.format | application/pdf | |
dc.language | eng | |
dc.rights | restricted access | |
dc.subject | Carbon tetrachloride (CCl4) | |
dc.subject | Diethylcarbamazine citrate | |
dc.subject | Liver fibrosis | |
dc.subject | Actinas / metabolismo | |
dc.subject | Animais | |
dc.subject | Biomarcadores / metabolismo | |
dc.subject | Tetracloreto de Carbono / farmacologia | |
dc.subject | Colágeno Tipo I / metabolismo | |
dc.subject | Dietilcarbamazina / farmacologia | |
dc.subject | Regulação para Baixo / /efeitos dos fármacos | |
dc.subject | Células Estreladas do Fígado / drug effects | |
dc.subject | Células Estreladas do Fígado / metabolismo | |
dc.subject | Fígado / efeitos dos fármacos | |
dc.subject | Fígado / metabolismo | |
dc.subject | Cirrose Hepática / induzido quimicamente | |
dc.subject | Cirrose Hepática / tratamento farmacológico | |
dc.subject | Cirrose Hepática / metabolismo | |
dc.subject | Masculino | |
dc.subject | Metaloproteinase 2 da Matriz / metabolismo | |
dc.subject | Camundongos | |
dc.subject | Camundongos Endogâmicos C57BL | |
dc.subject | NF-kappa B / metabolismo | |
dc.subject | Transdução de Sinais / Efeitos Colaterais Metabólicos de Drogas e Substâncias | |
dc.subject | Inibidor Tecidual de Metaloproteinase-1 / metabolismo | |
dc.subject | Fator de Crescimento Transformador beta1 / metabolismo | |
dc.subject | Proteínas Quinases p38 Ativadas por Mitógeno / metabolismo | |
dc.title | Diethylcarbamazine attenuates the expression of pro-fibrogenic markers and hepatic stellate cells activation in carbon tetrachloride-induced liver fibrosis | |
dc.type | Article | |